Cargando…

Predictive value and accuracy of [(18)F]FDG PET/CT modified response criteria for checkpoint immunotherapy in patients with advanced melanoma

PURPOSE: Immune checkpoint inhibitors (ICIs) are widely used in metastatic melanoma and dramatically alter the treatment of these patients. Given the high cost and potential toxicity, a reliable method for evaluating treatment response is needed. In this study, we assessed tumor response in patients...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ayati, Narjess, Jamshidi-Araghi, Zahra, Hoellwerth, Magdalena, Schweighofer-Zwink, Gregor, Hitzl, Wolfgang, Koelblinger, Peter, Pirich, Christian, Beheshti, Mohsen
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Berlin Heidelberg 2023
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10317870/ https://www.ncbi.nlm.nih.gov/pubmed/37140669 http://dx.doi.org/10.1007/s00259-023-06247-8

Ejemplares similares

Impact of [(18)F]FDG PET/CT in the Assessment of Immunotherapy-Induced Arterial Wall Inflammation in Melanoma Patients Receiving Immune Checkpoint Inhibitors
por: Ranjbar, Shaghayegh, et al.
Publicado: (2023)

Molecular Imaging in Primary Staging of Prostate Cancer Patients: Current Aspects and Future Trends
por: Manafi-Farid, Reyhaneh, et al.
Publicado: (2021)

Assessment of Treatment Response to Lenvatinib in Thyroid Cancer Monitored by F-18 FDG PET/CT Using PERCIST 1.0, Modified PERCIST and EORTC Criteria—Which One Is Most Suitable?
por: Rendl, Gundula, et al.
Publicado: (2022)

Feasibility of equivalent performance of 3D TOF [(18)F]-FDG PET/CT with reduced acquisition time using clinical and semiquantitative parameters
por: Pilz, Julia, et al.
Publicado: (2021)

Incremental Impact of [(68) Ga]Ga-PSMA-11 PET/CT in Primary N and M Staging of Prostate Cancer Prior to Curative-Intent Surgery: a Prospective Clinical Trial in Comparison with mpMRI
por: Szigeti, Florian, et al.
Publicado: (2021)

Accurate detection of intracranial extension of jugulotympanic paraganglioma by [(18)F]FDOPA-PET/CT comparing to MRI
por: Araghi, Zahra Jamshidi, et al.
Publicado: (2021)

Evolving Role of [(18)F]Flurocholine PET/CT in Assessing Primary Hyperparathyroidism: Can It Be Considered the First-Line Functional Imaging Approach?
por: Seyedinia, Seyedeh Sara, et al.
Publicado: (2023)

ImmunoPET: Antibody-Based PET Imaging in Solid Tumors
por: Manafi-Farid, Reyhaneh, et al.
Publicado: (2022)

The value of FDG PET/CT imaging in outcome prediction and response assessment of lymphoma patients treated with immunotherapy: a meta-analysis and systematic review
por: Kiamanesh, Zahra, et al.
Publicado: (2022)

Head-to-Head Comparison of CZT-SPECT and SPECT/CT Myocardial Perfusion Imaging: Interobserver and Intraobserver Agreement and Diagnostic Performance
por: Kalantari, Forough, et al.
Publicado: (2023)

Generalized Lymph Node Activation after Influenza Vaccination on (18)F FDG-PET/CT Imaging, an Important Pitfall in PET Interpretation
por: Ayati, Narjess, et al.
Publicado: (2017)

Evaluation of baseline fracture risk in younger postmenopausal women with breast cancer using different risk assessment methods
por: Schaffler-Schaden, Dagmar, et al.
Publicado: (2020)

Comparison between viral vector and mRNA based COVID-19 vaccination in prevalence and severity of regional immune reactions, and (18)F-FDG PET/CT features
por: Ayati, Narjess, et al.
Publicado: (2023)

Revisiting the Role of the CXCL13/CXCR5-Associated Immune Axis in Melanoma: Potential Implications for Anti-PD-1-Related Biomarker Research
por: Hoellwerth, Magdalena, et al.
Publicado: (2023)

Clinicopathological characteristics of thyroid cancer in the federal state of Salzburg
por: Rendl, Gundula, et al.
Publicado: (2017)

Targeted Palliative Radionuclide Therapy for Metastatic Bone Pain
por: Manafi-Farid, Reyhaneh, et al.
Publicado: (2020)

Appropriateness criteria of FDG PET/CT in oncology
por: Agrawal, Archi, et al.
Publicado: (2015)

Value of FDG PET/CT in the assessment of patients with colon cancer comparing to stand-alone CT
por: Akbari, Kaveh, et al.
Publicado: (2014)

FDG PET (and MRI) for Monitoring Immunotherapy in Alzheimer Disease
por: Høilund-Carlsen, Poul F., et al.
Publicado: (2023)

Immunotherapy Monitoring with Immune Checkpoint Inhibitors Based on [(18)F]FDG PET/CT in Metastatic Melanomas and Lung Cancer
por: Lopci, Egesta
Publicado: (2021)

Hepatic candidiasis mimicking lymphoma on (18)F-FDG PET/CT in a patient with T cell lymphoma
por: Schwerz, Sandra, et al.
Publicado: (2020)

COVID-19-Induced Reduction in Primary Melanoma Diagnoses: Experience from a Dermatopathology Referral Center
por: Hoellwerth, Magdalena, et al.
Publicado: (2021)

Additional Value of 2-[(18)F]FDG PET/CT Comparing to MRI in Treatment Approach of Anal Cancer Patients
por: Manafi-Farid, Reyhaneh, et al.
Publicado: (2020)

Phantom criteria for qualification of brain FDG and amyloid PET across different cameras
por: Ikari, Yasuhiko, et al.
Publicado: (2016)

(18)F-Fluorocholine PET/CT in the assessment of primary hyperparathyroidism compared with (99m)Tc-MIBI or (99m)Tc-tetrofosmin SPECT/CT: a prospective dual-centre study in 100 patients
por: Beheshti, Mohsen, et al.
Publicado: (2018)

FDG PET/CT in the Staging of Lung Cancer
por: Farsad, Mohsen
Publicado: (2020)

PET Criteria by Cancer Type from Imaging Interpretation to Treatment Response Assessment: Beyond FDG PET Score
por: Dondi, Francesco, et al.
Publicado: (2023)

Assessment of response to neoadjuvant radiochemotherapy with F-18 FLT and F-18 FDG PET/CT in patients with rectal cancer
por: Rendl, Gundula, et al.
Publicado: (2014)

The prognostic value of [(18)F]FDG PET/CT based response monitoring in metastatic melanoma patients undergoing immunotherapy: comparison of different metabolic criteria
por: Sachpekidis, Christos, et al.
Publicado: (2023)

Evaluation of serum Asymmetric Dimethyl Arginine concentrations in coronary artery disease patients without traditional cardiovascular risk factors
por: Ghayour-Mobarhan, Majid, et al.
Publicado: (2018)

Treatment efficacy of (153)Sm-EDTMP for painful bone metastasis
por: Ayati, Narjess, et al.
Publicado: (2013)

[(18)F]FDG PET/CT in the Evaluation of Melanoma Patients Treated with Immunotherapy
por: Mangas Losada, María, et al.
Publicado: (2023)

A Study on the Basic Criteria for Selecting Heterogeneity Parameters of F18-FDG PET Images
por: Forgacs, Attila, et al.
Publicado: (2016)

Lugano 2014 criteria for assessing FDG-PET/CT in lymphoma: an operational approach for clinical trials
por: Van Heertum, Ronald L, et al.
Publicado: (2017)

Performance of Deauville Criteria in ([18F])FDG-PET/CT Diagnostics of Giant Cell Arteritis
por: Siefert, Jeffrey, et al.
Publicado: (2023)

Prediction of Early Response to Immune Checkpoint Inhibition Using FDG-PET/CT in Melanoma Patients
por: Kudura, Ken, et al.
Publicado: (2021)

Pembrolizumab-Induced Sarcoid-Like Reaction: FDG-PET Scan Interpretation in the Era of Immunotherapy
por: Malaty, Shiva, et al.
Publicado: (2020)

FDG-PET/CT in the Monitoring of Lymphoma Immunotherapy Response: Current Status and Future Prospects
por: Al-Ibraheem, Akram, et al.
Publicado: (2023)

Diagnostic accuracy for the epileptogenic zone detection in focal epilepsy could be higher in FDG-PET/MRI than in FDG-PET/CT
por: Kikuchi, Kazufumi, et al.
Publicado: (2020)

The Role of (18)F-FDG PET/CT in Large-Vessel Vasculitis: Appropriateness of Current Classification Criteria?
por: Balink, H., et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_p37djqpgjn864458rna0kfnkuc